Jan 12 (Reuters) - Johnson & Johnson ( JNJ ) is
exploring a bid to acquire Intra-Cellular Therapies Inc ( ITCI )
, a biopharmaceutical company, Bloomberg News reported
on Sunday citing people familiar with the matter.